title: Can we improve the results of simultaneous pancreas-kidney transplantation?
authors.affiliation: Department of Nephrology, Hospital Saint-Louis, Paris, France.
authors.forename: S
authors.initials: S
authors.lastname: Fornairon
authors.forename: F
authors.initials: F
authors.lastname: Desgrandchamps
authors.forename: P
authors.initials: P
authors.lastname: Cattan
authors.forename: P
authors.initials: P
authors.lastname: Meria
authors.forename: M
authors.initials: M
authors.lastname: Anidjar
authors.forename: J
authors.initials: J
authors.lastname: Bedrossian
authors.forename: P
authors.initials: P
authors.lastname: Teillac
authors.forename: A
authors.initials: A
authors.lastname: Le Duc
authors.forename: C
authors.initials: C
authors.lastname: Legendre
mesh_terms: D000328:Adult; D016572:Cyclosporine / Q000627:therapeutic use; D003922:Diabetes Mellitus, Type 1 / Q000601:surgery*; D003928:Diabetic Nephropathies / Q000601:surgery*; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000188:drug therapy / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007668:Kidney; D007676:Kidney Failure, Chronic / Q000601:surgery; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology; D008875:Middle Aged; D009926:Organ Preservation / Q000379:methods; D010179:Pancreas; D016035:Pancreas Transplantation / Q000276:immunology / Q000502:physiology; D012189:Retrospective Studies; D016559:Tacrolimus / Q000627:therapeutic use; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus